Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table 3 from Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47
  1. Home
  2. Publications
  3. Supplementary Table 3 from Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47

Supplementary Table 3 from Preclinical Development of SGN-CD47M: Protease-Activated Antibody Technology Enables Selective Tumor Targeting of the Innate Immune Checkpoint Receptor CD47

Authors:
  • MLMatthew R. Levengood
    Matthew R. Levengood
  • CCChristopher M. Carosino
    Christopher M. Carosino
  • XZXinqun Zhang
    Xinqun Zhang
  • SLSasha Lucas
    Sasha Lucas
  • DODavid J. Ortiz
    David J. Ortiz
  • LWLori Westendorf
    Lori Westendorf
  • ACAlice P. Chin
    Alice P. Chin
  • AMArlan D. Martin
    Arlan D. Martin
  • AWAbbie Wong
    Abbie Wong
  • SHShawna M. Hengel
    Shawna M. Hengel
  • HSHao Sun
    Hao Sun
  • WZWeiping Zeng
    Weiping Zeng

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.32713816
Abstract
Supplementary Table 3. MMP2 and MMP9 quantification from select tumor models.
Keywords
  • SUPPLEMENTARY TABLE
  • CHECKPOINT RECEPTOR
  • PRECLINICAL DEVELOPMENT
  • ANTIBODY TECHNOLOGY
  • TECHNOLOGY ENABLES
  • ENABLES SELECTIVE
  • INNATE IMMUNE
  • IMMUNE CHECKPOINT
  • PROTEASE-ACTIVATED ANTIBODY
  • TABLE
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.